| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 78, 711-716, Copyright © 1994 by Endocrine Society
ARTICLES |
CJ Bagatell, JR Heiman, JE Rivier and WJ Bremner
Medical Service, Seattle Veterans Affairs Medical Center, Washington 98108.
The importance of androgens in establishing and maintaining sexual function in males of most species is well recognized. Estrogens also stimulate male sexual function in some species. In men, most studies of androgen effects on behavior have used hypogonadal men as an experimental model; much less is known about the role of endogenous testosterone (T) or estradiol (E2) in the regulation of behavior in healthy, eugonadal men. In a randomized, double-blind study, we used a GnRH antagonist, Nal-Glu, without T replacement, to induce acute, profound, reversible gonadal steroid deficiency in 9 normal men for 6 weeks (Nal-Glu alone). We also studied the effects of partial androgen replacement by administering Nal-Glu together with T enanthate, 50 mg im weekly, to 10 other men. A third group of 10 men received Nal-Glu plus T, 100 mg im weekly. We studied the role of endogenous E2 by administering Nal-Glu plus T, 100 mg im weekly, plus an aromatase inhibitor, testolactone (Teslac), 250 mg po qid, to 10 additional men (Nal - Glu + T + Teslac). Nine men received placebo injections and tablets. All subjects completed a behavioral questionnaire during the pretreatment period, at weeks 2, 4, and 6 of treatment, and at 3 weeks posttreatment. Men who received Nal-Glu alone became profoundly hypogonadal within 1 week after treatment began. Serum T levels did not change significantly in the controls and in the men who received full T replacement but decreased to approximately half the baseline level in men who received partial T replacement. E2 levels decreased profoundly in men who received Nal-Glu alone or Nal - Glu + T + Teslac and to a lesser degree in men who received partial T replacement. In men who received Nal-Glu alone, there were clinically and statistically significant decreases in the frequency of sexual desire, sexual fantasies, and intercourse at 4-6 weeks. These men also showed a strong trend (P = 0.55) towards decreased spontaneous erections after 4 and 6 weeks of treatment. A significant decrease in the frequency of masturbation was evident after 6 weeks. All measures returned to normal by posttreatment week 3. There was a trend toward increased aggression in the hypogonadal men, but this did not reach statistical significance. No changes in satisfaction or happiness with their partners were observed.(ABSTRACT TRUNCATED AT 400 WORDS)
This article has been cited by other articles:
 |
|
 |
|
  A. A. Yassin and F. Saad Testosterone and Erectile Dysfunction J Androl, November 1, 2008; 29(6): 593 - 604. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Armagan, N. N. Kim, I. Goldstein, and A. M. Traish Dose-Response Relationship Between Testosterone and Erectile Function: Evidence for the Existence of a Critical Threshold J Androl, July 1, 2006; 27(4): 517 - 526. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bloch, D. R. Rubinow, K. Berlin, K. R. Kevala, H.-Y. Kim, and P. J. Schmidt Monoamines and neurosteroids in sexual function during induced hypogonadism in healthy men. Arch Gen Psychiatry, April 1, 2006; 63(4): 450 - 456. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Kaufman and A. Vermeulen The Decline of Androgen Levels in Elderly Men and Its Clinical and Therapeutic Implications Endocr. Rev., October 1, 2005; 26(6): 833 - 876. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Bancroft The endocrinology of sexual arousal J. Endocrinol., September 1, 2005; 186(3): 411 - 427. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. D. Seftel, R. J. Mack, A. R. Secrest, and T. M. Smith Restorative Increases in Serum Testosterone Levels Are Significantly Correlated to Improvements in Sexual Functioning J Androl, November 1, 2004; 25(6): 963 - 972. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kelleher, A. J. Conway, and D. J. Handelsman Blood Testosterone Threshold for Androgen Deficiency Symptoms J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3813 - 3817. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Asthana, S. Bhasin, R. N. Butler, H. Fillit, J. Finkelstein, S. M. Harman, L. Holstein, S. G. Korenman, A. M. Matsumoto, J. E. Morley, et al. Masculine Vitality: Pros and Cons of Testosterone in Treating the Andropause J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2004; 59(5): M461 - M465. [Full Text] [PDF]
|
|
|
|
|
|
R. A. Anderson, A. M. Wallace, N. Sattar, N. Kumar, and K. Sundaram Evidence for Tissue Selectivity of the Synthetic Androgen 7{alpha}-Methyl-19-Nortestosterone in Hypogonadal Men J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2784 - 2793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kunelius, O. Lukkarinen, M. L. Hannuksela, O. Itkonen, and J. S. Tapanainen The Effects of Transdermal Dihydrotestosterone in the Aging Male: A Prospective, Randomized, Double Blind Study J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1467 - 1472. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Matsumoto Andropause: Clinical Implications of the Decline in Serum Testosterone Levels With Aging in Men J. Gerontol. A Biol. Sci. Med. Sci., February 1, 2002; 57(2): M76 - 99. [Full Text]
|
|
|
|
 |
|
 S. Bhasin, L. Woodhouse, R. Casaburi, A. B. Singh, D. Bhasin, N. Berman, X. Chen, K. E. Yarasheski, L. Magliano, C. Dzekov, et al. Testosterone dose-response relationships in healthy young men Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1172 - E1181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vermeulen Androgen Replacement Therapy in the Aging Male--A Critical Evaluation J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2380 - 2390. [Full Text] [PDF]
|
|
|
|
|
|
P. Cohan and S. G. Korenman Erectile Dysfunction J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2391 - 2394. [Full Text] [PDF]
|
|
|
|
|
|
K. K. Miller Androgen Deficiency in Women J. Clin. Endocrinol. Metab., June 1, 2001; 86(6): 2395 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. K. Miller, G. Sesmilo, A. Schiller, D. Schoenfeld, S. Burton, and A. Klibanski Androgen Deficiency in Women with Hypopituitarism J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 561 - 567. [Abstract] [Full Text]
|
|
|
|
|
|
R. A. Anderson, C. W. Martin, A. W. C. Kung, D. Everington, T. C. Pun, K. C. B. Tan, J. Bancroft, K. Sundaram, A. J. Moo-Young, and D. T. Baird 7{alpha}-Methyl-19-Nortestosterone Maintains Sexual Behavior and Mood in Hypogonadal Men J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3556 - 3562. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. C. W. Wu, R. Balasubramanian, T. M. T. Mulders, and H. J. T. Coelingh-Bennink Oral Progestogen Combined with Testosterone as a Potential Male Contraceptive: Additive Effects between Desogestrel and Testosterone Enanthate in Suppression of Spermatogenesis, Pituitary-Testicular Axis, and Lipid Metabolism J. Clin. Endocrinol. Metab., January 1, 1999; 84(1): 112 - 122. [Abstract] [Full Text]
|
|
|
|
|
|
J. W. Finkelstein, E. J. Susman, V. M. Chinchilli, M. R. D’Arcangelo, S. J. Kunselman, J. Schwab, L. M. Demers, L. S. Liben, and H. E. Kulin Effects of Estrogen or Testosterone on Self-Reported Sexual Responses and Behaviors in Hypogonadal Adolescents J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2281 - 2285. [Abstract] [Full Text]
|
|
|
|
|
|
B. M. Kudielka, J. Hellhammer, D. H. Hellhammer, O. T. Wolf, K.-M. Pirke, E. Varadi, J. Pilz, and C. Kirschbaum Sex Differences in Endocrine and Psychological Responses to Psychosocial Stress in Healthy Elderly Subjects and the Impact of a 2-Week Dehydroepiandrosterone Treatment J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1756 - 1761. [Abstract] [Full Text]
|
|
|
|
 |
|
 M R Zacharin and G L Warne Treatment of hypogonadal adolescent boys with long acting subcutaneous testosterone pellets Arch. Dis. Child., June 1, 1997; 76(6): 495 - 499. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. J. Bagatell and W. J. Bremner Androgens in Men -- Uses and Abuses N. Engl. J. Med., March 14, 1996; 334(11): 707 - 715. [Full Text] [PDF]
|
|
|
|
 |
|
 C. S Mantzoros, E. I Georgiadis, and D. Trichopoulos Contribution of dihydrotestosterone to male sexual behaviour BMJ, May 20, 1995; 310(6990): 1289 - 1291. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
